CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer (includes fallopian tube cancer and prima...
Phase 3
Indianapolis, Indiana, United States and 22 other locations
followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...
Phase 3
Indianapolis, Indiana, United States and 213 other locations
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....
Phase 3
Indianapolis, Indiana, United States and 176 other locations
in combination with pembrolizumab versus protocol-specific Investigator's choice chemotherapy in patients with platinum-resistant epithelial ovarian...
Phase 3
Indianapolis, Indiana, United States and 131 other locations
as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high fola...
Phase 3
Indianapolis, Indiana, United States and 153 other locations
in patients with platinum-resistant high-grade epithelial ovarian cancer, primary peritoneal, or fallopian tube cancer, wh...
Phase 3
Indianapolis, Indiana, United States and 207 other locations
This study aims to assess efficacy of Niraparib (GSK3985771) as maintenance treatment in participants with Stage III or IV ovarian cancer...
Phase 3
Indianapolis, Indiana, United States and 194 other locations
following response to front-line treatment in newly diagnosed ovarian cancer patients. Response to treatment will be analyzed based...
Phase 3
Indianapolis, Indiana, United States and 237 other locations
The primary objective is to compare pembrolizumab plus paclitaxel with or without bevacizumab to placebo plus paclitaxel with or without bevacizumab,...
Phase 3
Indianapolis, Indiana, United States and 186 other locations
and maintenance olaparib (MK-7339) in women with epithelial ovarian cancer (EOC), fallopian tube cancer, or primary perito...
Phase 3
Indianapolis, Indiana, United States and 226 other locations
Clinical trials
Research sites
Resources
Legal